Ad Header



The Pulse of the Pharmaceutical Industry

Ad Right Top

Latest News

FDA Approves Symproic for OIC

The U.S. FDA approved Symproic (naldemedine) 0.2 mg tablets C-II for treating opioid-induced constipation in adult patients with chronic non-cancer pain.

FDA Grants Approval for Bavencio

The U.S. FDA approved Bavencio (avelumab) Injection 20 mg/mL for ttreating adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma.


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2017 Focus: Top 10 Pipelines, Agenda 2017 and more!


Ad Right Bottom

Password Reset
Please enter your e-mail address. You will receive a new password via e-mail.

Main Navigation